These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Increased orexin levels in the cerebrospinal fluid the first year after a suicide attempt. Brundin L; Björkqvist M; Träskman-Bendz L; Petersén A J Affect Disord; 2009 Feb; 113(1-2):179-82. PubMed ID: 18533274 [TBL] [Abstract][Full Text] [Related]
11. Levels of nitric oxide metabolites in cerebrospinal fluid in cluster headache. Steinberg A; Wiklund NP; Brundin L; Remahl AI Cephalalgia; 2010 Jun; 30(6):696-702. PubMed ID: 20511209 [TBL] [Abstract][Full Text] [Related]
12. Involvement of corticotrophin-releasing factor and orexin-A in chronic migraine and medication-overuse headache: findings from cerebrospinal fluid. Sarchielli P; Rainero I; Coppola F; Rossi C; Mancini M; Pinessi L; Calabresi P Cephalalgia; 2008 Jul; 28(7):714-22. PubMed ID: 18479471 [TBL] [Abstract][Full Text] [Related]
13. Reduced CSF hypocretin-1 levels are associated with cluster headache. Barloese M; Jennum P; Lund N; Knudsen S; Gammeltoft S; Jensen R Cephalalgia; 2015 Sep; 35(10):869-76. PubMed ID: 25492975 [TBL] [Abstract][Full Text] [Related]
14. Hypocretin (orexin) loss in Parkinson's disease. Fronczek R; Overeem S; Lee SY; Hegeman IM; van Pelt J; van Duinen SG; Lammers GJ; Swaab DF Brain; 2007 Jun; 130(Pt 6):1577-85. PubMed ID: 17470494 [TBL] [Abstract][Full Text] [Related]
15. CSF hypocretin-1 levels are normal in multiple-system atrophy. Abdo WF; Bloem BR; Kremer HP; Lammers GJ; Verbeek MM; Overeem S Parkinsonism Relat Disord; 2008; 14(4):342-4. PubMed ID: 17977056 [TBL] [Abstract][Full Text] [Related]
16. Hypocretin (orexin) loss in Alzheimer's disease. Fronczek R; van Geest S; Frölich M; Overeem S; Roelandse FW; Lammers GJ; Swaab DF Neurobiol Aging; 2012 Aug; 33(8):1642-50. PubMed ID: 21546124 [TBL] [Abstract][Full Text] [Related]
17. CSF hypocretin-1 concentrations correlate with the level of fatigue in multiple sclerosis patients. Papuć E; Stelmasiak Z; Grieb P; Paweł G; Rejdak K Neurosci Lett; 2010 Apr; 474(1):9-12. PubMed ID: 20193740 [TBL] [Abstract][Full Text] [Related]
18. CSF orexin levels of Parkinson's disease, dementia with Lewy bodies, progressive supranuclear palsy and corticobasal degeneration. Yasui K; Inoue Y; Kanbayashi T; Nomura T; Kusumi M; Nakashima K J Neurol Sci; 2006 Dec; 250(1-2):120-3. PubMed ID: 17005202 [TBL] [Abstract][Full Text] [Related]
19. Hypocretins and primary headaches: neurobiology and clinical implications. Rainero I; De Martino P; Pinessi L Expert Rev Neurother; 2008 Mar; 8(3):409-16. PubMed ID: 18345971 [TBL] [Abstract][Full Text] [Related]
20. Normal hypocretin-1 (orexin-A) levels in the cerebrospinal fluid of patients with Huntington's disease. Meier A; Mollenhauer B; Cohrs S; Rodenbeck A; Jordan W; Meller J; Otto M Brain Res; 2005 Nov; 1063(2):201-3. PubMed ID: 16263095 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]